A Degli Antoni

A Reduction Grade of Lipodystrophy and Limited Side Effects after HAART Regimen with Raltegravir, Lamivudine, Darunavir and Ritonavir in an HIV-1 Infected Patient after Six Years of Antiretroviral Therapy

Issue: 

Vol 64, Issue 3: June (2015)

DOI: 

10.7727/wimj.2014.066

Pages: 

291–3

ABSTRACT

Received: 

12 Mar, 2014

Accepted: 

14 Apr, 2015

PDF Attachment: 

wimjjun2015_291_293.pdf

Journal Sections: 

Case Reports

Keywords: 

raltegravir

HIV-1 infection

lamivudine

Darunavir

ritonavir

severe lipodystrophy

Journal Authors: 

A Degli Antoni

LE Weimer

V Fragola

A Giacometti

F Sozio

e-Published: 14 Jul, 2015

• Read more about A Reduction Grade of Lipodystrophy and Limited Side Effects after HAART Regimen with Raltegravir, Lamivudine, Darunavir and Ritonavir in an HIV-1 Infected Patient after Six Years of Antiretroviral Therapy

A Reduced Grade of Liver Fibro-steatosis after Raltegravir, Maraviroc and Fosamprenavir in an HIV/HCV Co-infected Patient with Chronic Hepatitis, Cardiomyopathy, Intolerance to Nelfinavir and a Marked Increase of Serum Creatine Phosphokinase Levels ...

Issue: 

Vol 61, Issue 9 (2012)

DOI: 

10.7727/wimj.2011.194

Pages: 

932–6

ABSTRACT

PDF Attachment: 

dr_a_degli_antoni.qxd_.pdf

Journal Sections: 

Case Reports

Keywords: 

Antiretroviral treatment

chronic active hepatitis

fosamprenavir

HIV/HCV

maraviroc

raltegravir

Journal Authors: 

A Degli Antoni

LE Weimer

R Manfredi

V Fragola

C Ferrari

e-Published: 24 Jun, 2013

• Read more about A Reduced Grade of Liver Fibro-steatosis after Raltegravir, Maraviroc and Fosamprenavir in an HIV/HCV Co-infected Patient with Chronic Hepatitis, Cardiomyopathy, Intolerance to Nelfinavir and a Marked Increase of Serum Creatine Phosphokinase Levels ...